A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats

Psychopharmacology

Volumn 151, Issue 2-3, 2000, Pages 202-210

  Culver, K E ^a   Rosenfeld, J M ^b   Szechtman, H ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Dopamine; Locomotion; MAOI displaceable quinpirole binding site (MQB); Monoamine oxidase; Mouthing; Sensitization

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; CLORGYLINE; DOPAMINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; QUINPIROLE; SEROTONIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BINDING SITE; DRUG SENSITIZATION; LOCOMOTION; MALE; MOTOR ACTIVITY; MOUTH; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CLORGYLINE; DOPAMINE; DOPAMINE AGONISTS; MALE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; NEOSTRIATUM; QUINPIROLE; RATS; RATS, LONG-EVANS; SEROTONIN; STEREOTYPED BEHAVIOR;

EID: 0033842658     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002139900346     Document Type: Article

References (51)

1. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors
2. Behavioral response to SKF 38393 and quinpirole following chronic antidepressant treatment
3. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behavior in rats
4. Enhancement of amphetamine sensitization in a novel environment: The role of adrenal hormones
5. Discovery of antidepressant activity by forced swimming test may depend on pre-exposure of rats to a stressful situation
6. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
7. Chronic clorgyline and pargyline increase apomorphine-induced stereotypy in the rat
8. Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalon messenger RNA, and increases mu opiod receptors in mouse striatum
9. Monoamine oxidase inhibitor sensitive site implicated in sensitization to quinpirole
10. The development of behavioral sensitization to apomorphine is blocked MK-801
11. Biphasic effect of D-2 agonist quinpirole on locomotion and movements
12. D2-agonist quinpirole induces preservation of routes and hyperactivity but no preservation of movements
13. Longlasting consequences of chronic treatment with dopamine agonist quinpirole for the undrugged behavior of rats
14. Environmental modulation of both locomotor response and locomotor sensitization to the dopamine agonist quinpirole
15. Associational and non associational mechanisms in locomotor sensitization to the dopamine agonist quinpirole
16. Behavioral analysis of chronic amphetamine intoxication
17. Osmotic minipumps: A convenient program for weight adjusted filling concentrations
18. Biochemistry and pharmacology of moclobemide, a prototype RIMA
19. Effects of cocaine and quinpirole on perceptual and motor functions in baboons
20. Locomotor-activating effects on the D2 agonist bromocriptine show environment-specific sensitization following repeated injections
21. Lack of cross-sensitization between the locomotor-activating effects of bromocriptine and those of cocaine or heroin
22. Clorgyline displaces high affinity for sigma binding sites in C57BL/6 mouse brain
23. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
24. Comparison of monoamine oxidase-A inhibited by moclobemide in vitro and ex vivo in rats
25. 3H-spiperone to dopaminergic receptors
26. 3H]quinpirole binding in rat striatal membranes
27. 3H]quinpirole binding in brain by monoamine oxidase inhibitors: Evidence for a potential novel binding site
28. Novel drug interactions at CNS dopamine receptors: Potential role in psychopathology and toxicity
29. Permissive role of D-1 receptor stimulation for the expression of D-2 mediated behavioral responses: A quantitative phenomenological study in rats
30. In vitro and in vivo inhibition by benserazide of clorgyline-resistant amine oxidases in rat cardiovascular tissues
31. Behavioral effects of antidepressant drugs given repeatedly on the dopaminergic system
32. Conditioning and experiential factors affecting the development of sensitization to apomorphine
33. A behavioral and neurochemical analysis of chronic and selective monoamine oxidase inhibition
34. 3H]Spiperone binding in the rat striatum
35. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
36. Enduring change in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animals models of amphetamine psychosis
37. Animal models of stimulant-induced psychosis
38. Clorgyline-induced increases in presynaptic DA: Changes in the behavioral and neurochemical effects of amphetamine using in vivo microdialysis
39. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors
40. Asymmetrical influence of mesocortical dopamine depletion on stress ulcer development and subcortical dopamine synthesis in rats: Implications for psychopathology
41. Environmental and behavioral components of sensitization induced by the dopamine agonist quinpirole
42. Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole
43. Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy mechanism
44. Role of dopamine systems in obsessive-compulsive disorder: Implications from a novel psychostimulant-induced animal model
45. Locomotor sensitization to quinpirole: Environment-modulated increase in efficacy and context-dependent increase in potency
46. Localization of I2 imidazoline binding site on monoamine oxidases
47. On the reversibility of MAO inhibitors
48. Psychomotor-stimulant sensitization: A unitary phenomenon?
49. Downregulation of stereotyped behavior and production of latent locomotor behavior in mice treated continuously with quinpirole